prikaz prve stranice dokumenta Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization
  Download
PDF 711.08 KB
Scientific paper - Original scientific paper
Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization
Vaccines, 9 (2021), 2; 104. https://doi.org/10.3390/vaccines9020104
Gorun, Florin; Malita, Daniel; Ciohat, Ioana; Vilibi-Čavlek, Tatjana; Feier, Horea; Tabain, Irena; Craina, Marius; Cretu, Octavian; Navolan, Dan

Cite this document

Gorun, F., Malita, D., Ciohat, I., Vilibi Čavlek, T., Feier, H., Tabain, I. ... Navolan, D. (2021). Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization. Vaccines, 9. (2). doi: 10.3390/vaccines9020104

Gorun, Florin, et al. "Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization." Vaccines, vol. 9, no. 2, 2021. https://doi.org/10.3390/vaccines9020104

Gorun, Florin, Daniel Malita, Ioana Ciohat, Tatjana Vilibi Čavlek, Horea Feier, Irena Tabain, Marius Craina, Octavian Cretu and Dan Navolan. "Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization." Vaccines 9, no. 2 (2021). https://doi.org/10.3390/vaccines9020104

Gorun, F., et al. (2021) 'Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization', Vaccines, 9(2). doi: 10.3390/vaccines9020104

Gorun F, Malita D, Ciohat I, Vilibi Čavlek T, Feier H, Tabain I, and sur.. Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization. Vaccines [Internet]. 2021 January 29 [cited 2024 April 19];9(2). doi: 10.3390/vaccines9020104

F. Gorun, et al., "Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization", Vaccines, vol. 9, no. 2, January 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:126512. [Accessed: 19 April 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization
AuthorFlorin Gorun
AuthorDaniel Malita
AuthorIoana Ciohat
AuthorTatjana Vilibi-Čavlek
AuthorHorea Feier
AuthorIrena Tabain
AuthorMarius Craina
AuthorOctavian Cretu
AuthorDan Navolan
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Medical Microbiology and Parasitology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Medical Microbiology
Abstract (english)
Seronegative women are susceptible to primary rubella virus (RV) infection during pregnancy, which can cause fetal damage. Vaccination represents the main strategy in rubella prevention. The aim of this study was to analyze changes in the rubella seroprevalence and identify populations with a high susceptibility to RV. A cross-sectional study was performed on 6914 Caucasian fertile women who had Toxoplasma gondii, other viruses, Rubella, Cytomegalovirus, and the herpes simplex virus (TORCH) screening in two distinct periods-1452 at the Timișoara Municipal Hospital, Romania (Group 1: 2008-2010) and 5462 at the laboratory Bioclinica S.A., Timișoara, Romania (Group 2: 2015-2018). The RV seroprevalence decreased (Group 1 versus Group 2; 94.1% (92.7-95.2) versus 91.4% (90.6-92.1), OR = 0.76 (p = 0.0007)). According to the year of birth and eligibility to vaccination program, RV seroprevalence rates were 82.4% (76.8-86.8)/1997-2004, 85.4% (80.5-89.3)/1995-1996, 90.1% (89.0-91.1)/<1989, and 95.8% (94.7-96.6)/1989-1994. No significant difference in the RV seropositivity according to the place of residence was found. The overall RV susceptibility increased from 2008-2010 to 2015-2018. The highest susceptibility was found in women born between 1997-2004 eligible for measles-mumps-rubella (MMR) vaccine through the family practice system and the lowest in women born between 1989-1994 eligible for monovalent rubella vaccine conducted in schools.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleVaccines
Numberingvol. 9, no. 2, 104
e-ISSN2076-393X
DOIhttps://doi.org/10.3390/vaccines9020104
URN:NBNurn:nbn:hr:105:126512
Publication2021-01-29
Document URLhttps://www.mdpi.com/2076-393X/9/2/104
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2021-07-02 09:46:04